Kanker Payudara

Bridging the Genetic Divide: How Outliers Reveal the Hidden Architecture of Human Disease

• Genomics and Precision Medicine

Bridging the Genetic Divide: How Outliers Reveal the Hidden Architecture of Human Disease

Basiran August 7, 2026

In the rapidly evolving landscape of human genetics, researchers have long grappled with a fundamental dichotomy: the...

Read More Read more about Bridging the Genetic Divide: How Outliers Reveal the Hidden Architecture of Human Disease

The New Standard: Why Purpose-Driven Partnerships Are Reshaping Corporate Strategy

• Survivorship and Post-Treatment

The New Standard: Why Purpose-Driven Partnerships Are Reshaping Corporate Strategy

Asep Darmawan August 7, 2026

By Katie Mooneyham and Candace Day, National Breast Cancer Foundation In the modern marketplace, Corporate Social Responsibility...

Read More Read more about The New Standard: Why Purpose-Driven Partnerships Are Reshaping Corporate Strategy

Breaking the Cycle: The Pioneering Success of Mitochondrial Donation Therapy

• Genomics and Precision Medicine

Breaking the Cycle: The Pioneering Success of Mitochondrial Donation Therapy

Nana Muazin August 7, 2026

In a landmark achievement for reproductive medicine and genetic science, researchers at Newcastle University and The Newcastle...

Read More Read more about Breaking the Cycle: The Pioneering Success of Mitochondrial Donation Therapy

Gilead and Merck & Co. Shelve Promising Lung Cancer Trial Amidst Strategic Realignment

• Medical Research and Clinical Trials

Gilead and Merck & Co. Shelve Promising Lung Cancer Trial Amidst Strategic Realignment

Nana Muazin August 7, 2026

A pivotal Phase III trial combining Gilead Sciences’ Trodelvy (sacituzumab govitecan) with Merck & Co.’s Keytruda (pembrolizumab)...

Read More Read more about Gilead and Merck & Co. Shelve Promising Lung Cancer Trial Amidst Strategic Realignment

A Hard-Won Victory: The Regulatory Odyssey of Replimune’s Tudriqev

• Treatment Innovations

A Hard-Won Victory: The Regulatory Odyssey of Replimune’s Tudriqev

Ali Ikhwan August 7, 2026

On August 6, 2026, the landscape for advanced melanoma treatment shifted significantly as the U.S. Food and...

Read More Read more about A Hard-Won Victory: The Regulatory Odyssey of Replimune’s Tudriqev

Bridging the Gap: How Avatrombopag Offers a New Horizon for Chemotherapy-Induced Thrombocytopenia

• Clinical Oncology Education

Bridging the Gap: How Avatrombopag Offers a New Horizon for Chemotherapy-Induced Thrombocytopenia

Iffa Jayyana August 7, 2026

Introduction: The Silent Barrier to Cancer Treatment For patients battling gastrointestinal cancers, the road to recovery is...

Read More Read more about Bridging the Gap: How Avatrombopag Offers a New Horizon for Chemotherapy-Induced Thrombocytopenia

The Resilience of Pride: Richard Goldman’s Lifelong Commitment to Community and Compassion

• Integrative Oncology and Holistic Care

The Resilience of Pride: Richard Goldman’s Lifelong Commitment to Community and Compassion

Basiran August 7, 2026

Introduction: A Legacy Defined by Service In the tapestry of the LGBTQ+ rights movement, the history of...

Read More Read more about The Resilience of Pride: Richard Goldman’s Lifelong Commitment to Community and Compassion

A Challenging Tenure Begins: Erica Schwartz Takes the Helm at a Bifurcated CDC

• Chemotherapy and Targeted Therapy

A Challenging Tenure Begins: Erica Schwartz Takes the Helm at a Bifurcated CDC

Reynand Wu August 6, 2026

By BioPharma Investigative Desk August 6, 2026 In a move that marks a pivotal, if precarious, turning...

Read More Read more about A Challenging Tenure Begins: Erica Schwartz Takes the Helm at a Bifurcated CDC

The Erosion of Global Health Diplomacy: An Analysis of the Post-USAID Landscape

• Breast Cancer Legislation and Policy

The Erosion of Global Health Diplomacy: An Analysis of the Post-USAID Landscape

Reynand Wu August 6, 2026

Editorial Note: Originally published in May 2025, this comprehensive report has been updated to reflect the evolving...

Read More Read more about The Erosion of Global Health Diplomacy: An Analysis of the Post-USAID Landscape

The Quiet Revolution: Reclaiming Well-Being Through the Art of Deep Relaxation

• Integrative Oncology and Holistic Care

The Quiet Revolution: Reclaiming Well-Being Through the Art of Deep Relaxation

Rifan Muazin August 6, 2026

Published: August 6, 2026 Editor’s Note: This feature is part of our archival series, revisiting foundational insights...

Read More Read more about The Quiet Revolution: Reclaiming Well-Being Through the Art of Deep Relaxation